BackTable Urology
Ep. 193 Bladder Cancer Innovations: ESMO 2024 Highlights with Dr. Andrea Apolo
Dr. Andrea Apolo
So it's kind of nice in the adjuvant setting to let the patients have time off coming to clinic and seeing them every six weeks in terms of dosing because that's an FDA approved dosing schedule for pembrolizumab. So I think that's a plus that you can give it every six weeks.
0
💬
0
Comments
Log in to comment.
There are no comments yet.